Acute myeloid leukemia with mediastinal myeloid sarcoma refractory to acute myeloid leukemia therapy but responsive to L-asparaginase

International Journal of Hematology

Volumn 96, Issue 1, 2012, Pages 136-140

  Takahashi, Hiroyoshi ^a   Koh, Katsuyoshi ^a   Kato, Motohiro ^a   Kishimoto, Hiroshi ^a   Oguma, Eiji ^a   Hanada, Ryoji ^a  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

Acute myeloid leukemia; CD44; L asparaginase; Mediastinal tumor; Myeloid sarcoma

Indexed keywords

ASPARAGINASE; CD33 ANTIGEN; CD44V ANTIGEN; CYTARABINE; ETOPOSIDE; FLUDARABINE; GEMTUZUMAB OZOGAMICIN; HLA DR ANTIGEN; HYDROCORTISONE; IDARUBICIN; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE KIDNEY FAILURE; ADOLESCENT; ARTICLE; BLAST CELL; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; CAUSE OF DEATH; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS HEMODIAFILTRATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DUPLICATION; GENE REARRANGEMENT; GRANULOCYTIC SARCOMA; HEPATOSPLENOMEGALY; HUMAN; HYPERKALEMIA; HYPERPHOSPHATEMIA; HYPERURICEMIA; HYPOCALCEMIA; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MEDIASTINUM GRANULOCYTIC SARCOMA; PLEURA EFFUSION; SEPSIS; TANDEM REPEAT; THORACOSCOPY; TUMOR LYSIS SYNDROME;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; FATAL OUTCOME; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MEDIASTINAL NEOPLASMS; SARCOMA, MYELOID; TREATMENT OUTCOME;

EID: 84864972150     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1111-0     Document Type: Article

References (22)

1. Neiman RS, Barcos M, Berard C, Bonner H, Mann R, Rydell RE, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer. 1981;48:1426-37. (Pubitemid 11042596)
2. Menasce LP, Banerjee SS, Beckett E, Harris M. Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathology. 1999;34:391-8. (Pubitemid 29244162)
3. Woods WG, Kobrinsky N, Buckley J, Neudorf S, Sanders J, Miller L, et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study. J Clin Oncol. 1993;11: 1448-57. (Pubitemid 23228248)
4. Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H. WHO classification of tumours of haematopoietic and lymphoid tissue. Lyon: IARC; 2008.
5. Tsukimoto I, Tawa A, Horibe K, Tabuchi K, Kigasawa H, Tsuchida M, et al. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group. J Clin Oncol. 2009;27:4007-13.
6. Capizzi RL, Davis R, Powell B, Cuttner J, Ellison RR, Cooper MR, et al. Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia-a Cancer and Leukemia Group B Study. J Clin Oncol. 1988;6:499-508. (Pubitemid 18090699)
7. Grier HE, Gelber RD, Camitta BM, Delorey MJ, Link MP, Price KN, et al. Prognostic factors in childhood acute myelogenous leukemia. J Clin Oncol. 1987;5:1026-32. (Pubitemid 18056008)
8. Dusenbery KE, Howells WB, Arthur DC, Alonzo T, Lee JW, Kobrinsky N, et al. Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol. 2003;25: 760-8. (Pubitemid 37238764)
9. Bisschop MM, Revesz T, Bierings M, van Weerden JF, van Wering ER, Hahlen K, et al. Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia. Leukemia. 2001;15:46-9. (Pubitemid 32124067)
10. Reinhardt D, Creutzig U. Isolated myelosarcoma in children- update and review. Leuk Lymphoma. 2002;43:565-74. (Pubitemid 34232924)
11. Ramasamy K, Lim Z, Pagliuca A, Devereux S, Ho AY, Mufti GJ. Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: report of three cases and review of literature. Leuk Lymphoma. 2007;48:290-4. (Pubitemid 46994878)
12. Garaventa A, Dallorso S, Savioli C, Rosanda C, De Bernardi B. Granulocytic sarcoma presenting as an isolated mediastinal mass. Adifficult diagnostic problem.Acta Paediatr Scand. 1989;78:473-5. (Pubitemid 19133204)
13. Bown NP, Rowe D, Reid MM. Granulocytic sarcoma with translocation (9;11)(p22;q23): two cases. Cancer Genet Cytogenet. 1997;96:115-7. (Pubitemid 27287484)
14. Nounou R, Al-Zahrani HH, Ajarim DS, Martin J, Iqbal A, Naufal R, et al. Extramedullary myeloid cell tumours localised to the mediastinum: a rare clinicopathological entity with unique karyotypic features. J Clin Pathol. 2002;55:221-5. (Pubitemid 34250910)
15. Howell DL, Abramowsky CR. Granulocytic sarcoma presenting as a large mediastinal mass with acute spinal cord compression in a non-leukemic child. Pediatr Blood Cancer. 2005;44:527. (Pubitemid 40614505)
16. Tsai MH, Yang CP, Chung HT, Shih LY. Acute myeloid leukemia in a young girl presenting with mediastinal granulocytic sarcoma invading pericardium and causing superior vena cava syndrome. J Pediatr Hematol Oncol. 2009;31:980-2.
17. Campidelli C, Agostinelli C, Stitson R, Pileri SA. Myeloid sarcoma: extramedullary manifestation of myeloid disorders. Am J Clin Pathol. 2009;132:426-37.
18. Iizuka Y, Aiso M, Oshimi K, Kanemaru M, Kawamura M, Takeuchi J, et al. Myeloblastoma formation in acute myeloid leukemia. Leuk Res. 1992;16:665-71.
19. Misra S, Heldin P, Hascall VC, Karamanos NK, Skandalis SS, Markwald RR, et al. Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J. 2011;278:1429-43.
20. Irino T, Kitoh T, Koami K, Kashima T, Mukai K, Takeuchi E, et al. Establishment of real-time polymerase chain reaction method for quantitative analysis of asparagine synthetase expression. J Mol Diagn. 2004;6:217-24. (Pubitemid 39136649)
21. Iwamoto S, Mihara K, Downing JR, Pui CH, Campana D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest. 2007;117:1049-57. (Pubitemid 46556761)
22. Muller HJ, Boos J. Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol. 1998;28:97-113. (Pubitemid 28390409)